TherapeuticsMD (NASDAQ:TXMD) posted its quarterly earnings results on Monday. The company reported ($0.06) earnings per share for the quarter, meeting the analysts’ consensus estimate of ($0.06), AR Network reports. During the same quarter last year, the company posted ($0.06) earnings per share. TherapeuticsMD Inc. (NYSEMKT:TXMD) weekly performance is -5.24%. On last trading day company shares ended up $3.80. Analysts mean target price for the company is $9.75. TherapeuticsMD Inc. (NYSEMKT:TXMD) distance from 50-day simple moving average (SMA50) is -34.11%.
Rockwell Medical, Inc. (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the treatment of iron replacement, secondary hyperparathyroidism and hemodialysis, will hold its quarterly conference call to discuss first quarter results on Monday, May 12, 2014 at 4:30pm Eastern Time. Rockwell Medical Inc. (NASDAQ:RMTI) shares advanced 10.10% in last trading session and ended the day on $11.45. RMTI gross Margin is 12.80% and its return on assets is -128.40%.Rockwell Medical Inc. (NASDAQ:RMTI) quarterly performance is 8.22%.
Aerie Pharmaceuticals Inc. (NASDAQ:AERI) announced that its first quarter 2014 financial results will be released after the market closes on Monday May 12 2014. Aerie Pharmaceuticals Inc. (NASDAQ:AERI) shares moved up 7.92% in last trading session and was closed at $14.85, while trading in range of $13.66 – $15.44. Aerie Pharmaceuticals Inc. (NASDAQ:AERI) year to date (YTD) performance is -17.32%.
Chardan Capital initiated coverage on shares of NanoViricides (NASDAQ:NNVC) in a research report released on Thursday morning, TheFlyOnTheWall.com reports. The firm issued a buy rating on the stock. NanoViricides Inc. (NYSEMKT:NNVC) ended the last trading day at $3.30. Company weekly volatility is calculated as 7.19% and price to cash ratio as 10.54.NanoViricides Inc. (NYSEMKT:NNVC) showed a positive weekly performance of 8.91%.